Swanson

Dual Ginseng Plus

D
N+ Score64
Omega & Fish OilServing: 1 Capsule(s)Type: Botanical

Swanson Dual Ginseng Plus is a botanical supplement featuring a blend of adaptogenic herbs. Each capsule contains 200mg of American Ginseng root extract, 200mg of Ashwagandha, 200mg of Eleuthero root extract, 100mg of American Ginseng, and 90mg of Korean Ginseng Root Extract. With an N+ Score of 64 and a grade of D, this product falls into the average tier, reflecting a 50% ingredient adequacy and 25% formula completeness. Notably, none of the individual herbal ingredients are present at clinically studied dosages. Despite 100% label transparency, the product's overall effectiveness may be limited for those seeking clinically validated doses of these botanicals. This supplement, containing a total of 5 ingredients, may appeal to individuals interested in a general blend of ginseng and adaptogenic herbs.

About This Product

Dual Ginseng Plus by Swanson is a omega & fish oil supplement containing 5 active ingredients. It has earned an N+ Score of 64/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (5 ingredients)

IngredientAmountDose Adequacy
Eleuthero (root) extract200.000 mgN/A
American Ginseng100.000 mgN/A
Ashwagandha200.000 mgN/A
American Ginseng root extract200.000 mgN/A
Korean Ginseng Root Extract90.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.